HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

AE9C90CB

a potent and selective M3 muscarinic antagonist for the treatment of overactive bladder

Also Known As:

N-((1R, 5S, 6R)-3-azabicyclo(3.1.0)hex-6-ylmethyl)-2-hydroxy-N-methyl-2, 2-diphenylacetamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - AE9C90CB: 1

Experts

1.	Babu, V: 1 article (07/2010)
2.	Bansal, V: 1 article (07/2010)
3.	Chugh, A: 1 article (07/2010)
4.	Garg, M: 1 article (07/2010)
5.	Gupta, S: 1 article (07/2010)
6.	Krishna, N S: 1 article (07/2010)
7.	Kumar, N: 1 article (07/2010)
8.	Malhotra, S: 1 article (07/2010)
9.	Meru, A V: 1 article (07/2010)
10.	Ray, A: 1 article (07/2010)

Related Diseases

1.

Overactive Urinary Bladder (Overactive Bladder)

07/01/2010 - "Therefore, AE9C90CB may be a promising compound for the treatment of overactive bladder with reduced potential to cause dry mouth than currently available antimuscarinic drugs."
07/01/2010 - "AE9C90CB (N- [(1R, 5S, 6R)-3-azabicyclo [3.1.0] hex-6-ylmethyl]-2-hydroxy-N-methyl-2, 2-diphenylacetamide), a novel muscarinic receptor antagonist, was synthesized for the treatment of overactive bladder. "
07/01/2010 - "AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder."

Related Drugs and Biologics

1.	Muscarinic Antagonists
2.	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)